title: Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhage.
authors.affiliation: Department of Physiology, Loma Linda University of Medicine, Loma Linda, CA 92354, USA.
authors.forename: Hidenori
authors.initials: H
authors.lastname: Suzuki
authors.forename: Yu
authors.initials: Y
authors.lastname: Hasegawa
authors.forename: Wanqiu
authors.initials: W
authors.lastname: Chen
authors.forename: Kenji
authors.initials: K
authors.lastname: Kanamaru
authors.forename: John H
authors.initials: JH
authors.lastname: Zhang
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002536:Cerebral Arteries / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D004347:Drug Interactions; D054638:Dual Specificity Phosphatase 1 / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage; D053495:Osteopontin / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D034741:RNA, Small Interfering / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D015854:Up-Regulation; D020301:Vasospasm, Intracranial / Q000150:complications / Q000378:metabolism / Q000517:prevention & control*
chemical_list: D009842:Oligopeptides; D034741:RNA, Small Interfering; D011994:Recombinant Proteins; D053495:Osteopontin; C058161:glycyl-arginyl-glycyl-aspartyl-seryl-proline; D054638:Dual Specificity Phosphatase 1